A population-based cohort study using administrative health data from British Columbia looked at NIDDM patients who also had an IMID (i.e., rheumatoid arthritis, psoriatic disease, ankylosing spondylitis, inflammatory bowel disease, or a systemic autoimmune rheumatic disease) and newly initiated a GLP-1-RA or dipeptidyl peptidase-4 inhibitors (DPP-4is) between 2010 and 2021
The reduction in DNA fragmentation was identified as a key predictor of improved sperm motility, and combined improvements in sperm vitality and DNA integrity further enhanced the likelihood of better motility
For additional assistance, call Stericycle at 1-800-805-3093 between the hours of 8 a.m
Clin Cosmet Investig Dermatol 10, 147153.CrossRefGoogle ScholarPubMed Tong, J, Fitzmaurice, PS, Moszczynska, A, et al
GIP activation : Boosts insulin sensitivity and amplifies GLP-1 effects for greater fat loss efficiency